IL141176A0 - Targeted alphavirus and alphaviral vectors - Google Patents
Targeted alphavirus and alphaviral vectorsInfo
- Publication number
- IL141176A0 IL141176A0 IL14117699A IL14117699A IL141176A0 IL 141176 A0 IL141176 A0 IL 141176A0 IL 14117699 A IL14117699 A IL 14117699A IL 14117699 A IL14117699 A IL 14117699A IL 141176 A0 IL141176 A0 IL 141176A0
- Authority
- IL
- Israel
- Prior art keywords
- alphaviral vectors
- alphavirus
- targeted
- targeted alphavirus
- alphaviral
- Prior art date
Links
- 241000710929 Alphavirus Species 0.000 title 1
- 239000013598 vector Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/36011—Togaviridae
- C12N2770/36111—Alphavirus, e.g. Sindbis virus, VEE, EEE, WEE, Semliki
- C12N2770/36122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/36011—Togaviridae
- C12N2770/36111—Alphavirus, e.g. Sindbis virus, VEE, EEE, WEE, Semliki
- C12N2770/36141—Use of virus, viral particle or viral elements as a vector
- C12N2770/36143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/36011—Togaviridae
- C12N2770/36111—Alphavirus, e.g. Sindbis virus, VEE, EEE, WEE, Semliki
- C12N2770/36141—Use of virus, viral particle or viral elements as a vector
- C12N2770/36145—Special targeting system for viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2810/00—Vectors comprising a targeting moiety
- C12N2810/40—Vectors comprising a peptide as targeting moiety, e.g. a synthetic peptide, from undefined source
- C12N2810/405—Vectors comprising RGD peptide
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2810/00—Vectors comprising a targeting moiety
- C12N2810/50—Vectors comprising as targeting moiety peptide derived from defined protein
- C12N2810/80—Vectors comprising as targeting moiety peptide derived from defined protein from vertebrates
- C12N2810/85—Vectors comprising as targeting moiety peptide derived from defined protein from vertebrates mammalian
- C12N2810/855—Vectors comprising as targeting moiety peptide derived from defined protein from vertebrates mammalian from receptors; from cell surface antigens; from cell surface determinants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Wood Science & Technology (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Animal Behavior & Ethology (AREA)
- Gastroenterology & Hepatology (AREA)
- Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Plant Pathology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US9513898P | 1998-07-30 | 1998-07-30 | |
| PCT/US1999/017345 WO2000011201A1 (en) | 1998-07-30 | 1999-07-30 | Targeted alphavirus and alphaviral vectors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL141176A0 true IL141176A0 (en) | 2002-02-10 |
Family
ID=22250057
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL14117699A IL141176A0 (en) | 1998-07-30 | 1999-07-30 | Targeted alphavirus and alphaviral vectors |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP1100944A1 (en) |
| JP (1) | JP2002523053A (en) |
| AU (1) | AU5247199A (en) |
| CA (1) | CA2337905A1 (en) |
| IL (1) | IL141176A0 (en) |
| WO (1) | WO2000011201A1 (en) |
| ZA (1) | ZA200104382B (en) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002010417A2 (en) * | 2000-08-02 | 2002-02-07 | Xencor | Methods and compositions for the construction and use of viral envelops as display particles |
| CA2575591A1 (en) | 2003-08-08 | 2005-02-17 | Yuji Shino | A pharmaceutical composition for treatment of cancers |
| BR112015023205A2 (en) * | 2013-03-14 | 2017-07-18 | Takeda Vaccines Inc | compositions and methods for live attenuated alphavirus formulations |
| CN107456463B (en) * | 2014-08-26 | 2022-10-14 | 广州威溶特医药科技有限公司 | Application of alphavirus in preparing anti-tumor medicine |
| EP3762023A4 (en) * | 2018-03-05 | 2021-12-29 | New York University | Induction and enhancement of antitumor immunity involving sindbis virus vectors expressing immune checkpoint proteins |
| WO2023230675A1 (en) * | 2022-06-03 | 2023-12-07 | Alphinia Pty Ltd | Method, use, and kit relating to an rna virus |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5091309A (en) * | 1986-01-16 | 1992-02-25 | Washington University | Sindbis virus vectors |
| US5811407A (en) * | 1997-02-19 | 1998-09-22 | The University Of North Carolina At Chapel Hill | System for the in vivo delivery and expression of heterologous genes in the bone marrow |
| US6432699B1 (en) * | 1997-03-28 | 2002-08-13 | New York University | Viral vectors having chimeric envelope proteins containing the IgG-binding domain of protein A |
| ZA988446B (en) * | 1997-09-18 | 2000-03-22 | Res Dev Foundation | Production of vaccines using arthropod vectored viruses. |
-
1999
- 1999-07-30 IL IL14117699A patent/IL141176A0/en unknown
- 1999-07-30 JP JP2000566453A patent/JP2002523053A/en active Pending
- 1999-07-30 WO PCT/US1999/017345 patent/WO2000011201A1/en not_active Ceased
- 1999-07-30 AU AU52471/99A patent/AU5247199A/en not_active Abandoned
- 1999-07-30 EP EP99937686A patent/EP1100944A1/en not_active Withdrawn
- 1999-07-30 CA CA002337905A patent/CA2337905A1/en not_active Abandoned
-
2001
- 2001-05-28 ZA ZA200104382A patent/ZA200104382B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU5247199A (en) | 2000-03-14 |
| EP1100944A1 (en) | 2001-05-23 |
| JP2002523053A (en) | 2002-07-30 |
| CA2337905A1 (en) | 2000-03-02 |
| ZA200104382B (en) | 2002-08-28 |
| WO2000011201A1 (en) | 2000-03-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL128869A0 (en) | Pyrozolopyrimidines and pyrazolotriazines | |
| AU137668S (en) | Facial mask | |
| AU137669S (en) | Facial mask | |
| GB2348796B (en) | Enhanced personal cooling garment | |
| GB2341315B (en) | Head restraint | |
| AU696163B3 (en) | Head worn entertainment and communication device | |
| GB2368951B (en) | Authentication methods and systems | |
| AU4843500A (en) | Destructible surfactants and uses thereof | |
| GB2352523B (en) | Fluid-gauging systems and methods | |
| IL141176A0 (en) | Targeted alphavirus and alphaviral vectors | |
| GB9827746D0 (en) | Password generation and recovery system | |
| GB9820262D0 (en) | An improved safety helmet | |
| GB9802467D0 (en) | Improved security arrangements | |
| GB9720448D0 (en) | Security devices | |
| SI1029069T1 (en) | Alphavirus vectors | |
| GB9813747D0 (en) | Security arrangement and device | |
| GB9707121D0 (en) | Personal security system | |
| GB9810682D0 (en) | Safety and anti-theft device | |
| GB0102890D0 (en) | Personal safety and information system | |
| ZA9811735B (en) | 4-hydroxyquinoline-3-carboxamides and hydrazides as antiviral agents. | |
| TW354973U (en) | Safe and environment-friendly playground | |
| EG21695A (en) | Pin-screw-ajusting and safe | |
| TW331958U (en) | Impact type personal alarm | |
| GB2322156B (en) | Padlock protector | |
| PL319562A1 (en) | Safe neck-tie |